Acadian Asset Management LLC Enzo Biochem Inc Transaction History

Acadian Asset Management LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$2.9 - $3.47 $24,009 - $28,728	-8,279 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$3.17 - $4.09 $26,244 - $33,861	8,279 New	8,279 $26,000
Q3 2020 Nov 09, 2020	SELL	$2.02 - $3.02 $59,497 - $88,951	-29,454 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$2.12 - $3.22 $226,566 - $344,124	-106,871 Reduced 78.39%	29,454 $66,000
Q1 2020 May 11, 2020	SELL	$1.82 - $3.87 $22,673 - $48,212	-12,458 Reduced 8.37%	136,325 $345,000
Q4 2019 Feb 06, 2020	SELL	$2.57 - $3.68 $67,657 - $96,879	-26,326 Reduced 15.03%	148,783 $391,000
Q3 2019 Nov 07, 2019	SELL	$3.01 - $4.0 $30,587 - $40,648	-10,162 Reduced 5.48%	175,109 $631,000
Q2 2019 Aug 08, 2019	SELL	$2.79 - $4.31 $378,856 - $585,259	-135,791 Reduced 42.29%	185,271 $625,000
Q1 2019 May 09, 2019	SELL	$2.54 - $4.02 $201,010 - $318,134	-79,138 Reduced 19.77%	321,062 $876,000
Q4 2018 Feb 07, 2019	SELL	$2.46 - $4.2 $144,771 - $247,170	-58,850 Reduced 12.82%	400,200 $1.11 Million
Q3 2018 Oct 30, 2018	SELL	$3.81 - $5.53 $83,309 - $120,918	-21,866 Reduced 4.55%	459,050 $1.89 Million
Q2 2018 Jul 24, 2018	SELL	$5.06 - $6.78 $338,478 - $453,534	-66,893 Reduced 12.21%	480,916 $2.49 Million
Q1 2018 Apr 12, 2018	SELL	$5.43 - $8.36 $2 Million - $3.08 Million	-368,112 Reduced 40.19%	547,809 $3 Million
Q4 2017 Jan 18, 2018	SELL	$8.15 - $10.55 $691,160 - $894,692	-84,805 Reduced 8.47%	915,921 $7.47 Million
Q3 2017 Oct 13, 2017	BUY	$10.45 - $11.44 $10.5 Million - $11.4 Million	1,000,726	1,000,726 $10.5 Million

15.4M

2.3K

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $32.2M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.